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ofscientific detail may be excessive for anyone not directly involved with the specific
field of research, but the authors appear to have deliberately chosen to include,
rather than exclude, scientific information throughout this text.
Part IV, Repair, presents in vivo experiments of ligamentous response to stress,
including experimental studies on anterior cruciate ligament grafts. Animal models
for knee ligament research are described.
Part V, Clinical Studies, covers abroad range oftopics, includingclinical measure-
ments of knee stability, diagnostic imaging, the fate of the non-operated knee
ligament injury, and complications and results of knee ligament surgery. One may
wonder if this last section does not belong in the Patient Care chapter at the
beginning of the text. The authors, however, have consciously elected to stress the
scientific quality ofthisvolume, placing the clinical studies at the end.
Overall, this is an excellent book for anyone who is closely involved with treating
knee ligament injuries, as well as for anyone who is interested in pursuing any
research in this rapidly expanding field. By collecting such an impressive amount of
scientific data in onevolume, the editors have certainly created thegold standard for
any textbook on knee ligament injuries.
NoAH D. WEISS
DepartmentofOrthopaedics andRehabilitation
Yale University SchoolofMedicine
LAUNCHING THE ANTIBIOTIC ERA: PERSONALACCOUNTS OF THE DISCOVERY AND USE
OF THE FIRST ANTIBIOTICS. Edited by Carol L. Moberg and Zanvil A. Cohn. New
York, The Rockefeller University Press, 1990. 97 pp. No price.
The final decade of the twentieth century is destined to be punctuated repeatedly
byfiftieth anniversaries, many related to the unprecedented events ofWorld War II,
which dominated the historical period between 1939 and 1945. But there were also
some important scientific discoveries occurring at that difficult time. Since I was
unable to attend the symposium held at the Rockefeller University in October 1989,
commemorating the fiftieth anniversary of gramicidin's discovery by Rene Dubos, I
was pleased to review this publication. And why have such a symposium at all, not to
mention publishing it, too? Gramicidin was one of the first naturally occurring
antibiotics to be obtained through the process of scientific inquiry, and it is still in
use. This is an appropriate time to commemorate the launching ofthe antibiotic era.
Because of such publications as this, exploits and personal stories of triumphs and
false leads will not be lost to posterity.
The symposium participants have a number ofwonderful scientific tales to weave.
One is the Rollin Hotchkiss account ofhisworkwith Rene Dubos at the Rockefeller
Institute Hospital. Dubos had arrived in 1927, to begin work with Oswald T. Avery,
and to test his conviction that soils contained a self-purifying environment in which
there might be agents that could destroy some of the gram-positive bacteria associ-
ated with human disease. By Christmas of 1939, Hotchkiss and Dubos were each
giving papers at a bacteriology meeting in New Haven, Connecticut, describing
tyrocidine and gramicidin, which had been extracted with organic solvents from
peptone cultures ofBacillus brevis. Gramicidin's discovery had effects beyond its role
as an antibacterial agent that forms channels in bacterial cell walls and alters the
permeability ofcell membranes.BOOK REVIEWS
The first Dubos paper on Bacillus brevis makes note ofAlexander Fleming's 1929
work at Oxford on penicillin's inhibitory properties. In turn, when Dubos presented
his work in 1940, at the opening of the International Congress of Microbiology in
New York, Professor Howard Florey rose to say that the first gramicidin reports by
Dubos had helped encourage the Oxford group to reconsider penicillin ten years
later. The antibiotic concept was accepted, and the search had begun in earnest.
World War II intervened, keeping Norman Heatley from traveling to Denmark
and studying some newer micromethodology. Instead, he was asked by Florey to
remain at the William Dunn School of Pathology and work on the purification of
penicillin. Heatley succeeded in transferring penicillin from an organic to an
aqueous solvent, afirst important step in purification, whichprovided Floreywith the
material he needed for his 1940 mice protection experiments. Heatley gives an
absolutely riveting account ofboth the 1928 discovery ofthe penicillin effect and the
incredible difficulty in finding enough culture vessels to grow Penicillium notatum in
wartime England. Chance led Heatley to the ceramics manufacturer, James MacIn-
tyre and Company, which utilized clay and an old slipcast process to manufacture
rapidly the first batch of 174 vessels by December 23, 1940. These were seeded with
fungal spores only two months after the sketches had been brought to the company.
A few mice and six selected human subjects, two ofwhom died, initiated the massive
efforts which followed in the development ofpenicillin. Surely, it was avery different
world.
Ted Woodward ofthe University ofMaryland was fortunate to have accompanied
the late Joseph Smadel to Kuala Lumpur, Malaya, in 1948 to test the efficacy of the
first broad-spectrum antibiotic, chloramphenicol. In 1947, P.R. Burkholder at Yale
had noted that a new soil actinomycete from a field near Caracas, Venezuela,
inhibited growth of both gram-positive and gram-negative organisms. The soil
organism was Streptomyces venezuelae, from which chloramphenical was obtained.
Woodward gives an interesting account of the group's arrival in Kuala Lumpur and
the immediate treatment oftheir first patient, a young Malayan soldier.
George Mackaness, now retired as president of the Squibb Institute for Medical
Research, provides an equally exciting account ofthe emergence of isonicotinic acid
hydrazide, or isoniazid, as the anti-tuberculous agent of the twentieth century. Five
years after the introduction of streptomycin, there had been no reduction in the
number ofbeds occupied by patients with tuberculosis; however, five years after the
discovery ofisoniazid, 80 percent ofsuch designated beds were emptied.
In addition to these historical accounts regarding the discovery of some well-
known antibiotics, there are many illuminating and amusing stories about Rene
Dubos and the influence of both his person and his intellect on the advance of
science. Carol Moberg of the Rockefeller Institute tells of a fateful voyage on the
Rochambeau. Aboard ship, Rene Dubos met Selman Waksman, who offered Dubos
a fellowship at Rutgers to study bacteriology. When Dubos was later denied a
National Research Council fellowship because he was not a U.S. citizen, his fellow
Frenchman, Alexis Carrel, invited Dubos to lunch at the Rockefeller, and purposely
sat him next to Oswald Avery. The rest, as they say, is history.
This book isdelightful in its style, organization, and choice ofphotographs. Place it
on your shelf, right up there next to Microbe Hunters and Eleven Blue Men. Take it
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down frequently to recall, with awe and wonderment, the beginning of an epoch
initiated with gramicidin's discovery by Rene Dubos, a younggraduate ofthe French
Institute National Agronomique, who apparently had excelled in everything-except
microbiology.
FRANKJ. BIA
Departments ofInternalMedicine andLaboratoryMedicine
Yale University SchoolofMedicine
WANDERJAHR. THE EDUCATION OF A SURGEON. By Edward D. Churchill. Nantucket,
MA, Science History Publications, 1990. 213 pp. $18.95.
As we train in medicine, we learn of Ghon complexes, Leriche syndrome, and
Roux-en-Y abdominal operations, yet we know very little about the personalities
behind these names. When did these scientists and doctors exist, and where did they
live? Wander]ahr. The Education ofa Surgeon, edited and annotated by J. Gordon
Scannell, M.D., an emeritus Professor of Surgery at Massachusetts General Hospi-
tal, describes many of the characters that dominated medicine and surgery in the
early twentieth century.
Dr. Edward D. Churchill was the John Homans Professor of Surgery at Harvard
Medical School from 1931 to 1961 and an important figure in the development of
thoracic surgery. In 1926, fresh out of his residency training, he was granted a
Moseley Travelling Fellowship, entitling him to his year ofwandering, during which
he visited the pioneers ofthe field ofthoracic surgery. "His Wanderjahr took him to
Blair Bell in Liverpool; to Berlin and Prague; to Sauerbruch in Munich; to deQuer-
vain, Kocher's successor in Bern; to Enderlen in Heidelberg, Krogh in Copenhagen,
Brauer in Hamburg." His recollection of this year and its influence on the future
events ofhisbrilliant career are presented in informal travelogue fashion, based on a
series oforal history interviews conducted as Churchill was nearing retirement.
Herewe read ofapromisingyoungAmerican surgeonwith the luxuryof12 months
to visit the great laboratories of Europe, to ski in the Bavarian Alps, to drink port in
Cambridge, and to honeymoon at the Savoy. He remembers the excitement of
thoracoplasty operations for tuberculosis, the failures of treating asthma surgically,
and the first heart-lung machines. Churchill describes the German nationalism of
Sauerbruch and the meticulous technique of Brauer. Closer to home, he offers his
point ofview of the rivalry between Harvey Cushing's Peter Bent Brigham Hospital
surgery program and Churchill's own Massachusetts General Hospital program.
This is a short book, one that can be read in one sitting. While it does not offer a
complete discourse on the development of thoracic surgery, it does serve its
purpose-to bring the reader to Europe between the World Wars and to Harvard in
the days ofCushing. To the historian ofmedicine, it offers a personal glimpse ofthe
towering personalities in modern surgery. And to the uninitiated medical student,
like me, it transforms the Kochers and Halsteads from surgical instruments to men of
science.
JAMES CHANG
MedicalStudent
Yale University SchoolofMedicine